This application for supplemental funding describes experiments in parallel to a broader program aimed at advancing our understanding of prokaryotic cell division as a strategy for developing new antibiotics. In analogy to treating cancer by inhibiting the cytokinesis-modulating protein, tubulin, the homologous bacterial cell division protein, FtsZ, may provide an avenue for curing resistant infections. The proposed experiments in this Supplement will explore the chemistry, biochemistry and microbiology of zantrin Z3, a small molecule inhibitor of FtsZ. Although this compound has been known in the literature for many years, it was originally described in the context of many unselective inhibitors. We were able to demonstrate cross-strain specificity and the absence of unselective inhibition mechanisms common to many inhibitors studied to date. We will use synthetic chemistry, biochemical assays for GTPase inhibition, nuclear magnetic resonance spectroscopy (NMR), and conduct collaborative experiments in X-ray crystallography in order to fully understand how the function of FtsZ is modulated by analogs of this lead compound. Collectively these experiments will advance our understanding of the zantrin Z3 pharmacophore and enable the design of new compounds that will serve as leads in the search for new medicines to treat infection.

Public Health Relevance

The proposed research described in this Supplement will complement the Parent Award by revealing the details of how a small molecule inhibits the activity of a protein (FtsZ) that bacteria need to survive. Preventing it from functioning may be an effective strategy for curing infections that are resistant to antibiotics that target other processes in bacteria. Many bacteria are resistant to most antibiotics that are used today and this research will help in the discovery of new antibiotics to treat infections from these resistant mutants of bacteria.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
3R01AI080931-04S1
Application #
8629524
Study Section
Synthetic and Biological Chemistry B Study Section (SBCB)
Program Officer
Franceschi, Francois J
Project Start
2010-06-01
Project End
2015-05-31
Budget Start
2013-09-01
Budget End
2014-05-31
Support Year
4
Fiscal Year
2013
Total Cost
$44,690
Indirect Cost
$11,152
Name
University of California Davis
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Moore, Jared T; Soldi, Cristian; Fettinger, James C et al. (2013) Catalytic Alkene Cyclization Reactions for the Stereoselective Synthesis of Complex "Terpenoid-like" Heterocycles. Chem Sci 4:292-296
Jimenez-Oses, Gonzalo; Brockway, Anthony J; Shaw, Jared T et al. (2013) Mechanism of alkoxy groups substitution by Grignard reagents on aromatic rings and experimental verification of theoretical predictions of anomalous reactions. J Am Chem Soc 135:6633-42
Sorto, Nohemy A; Painter, Phillip P; Fettinger, James C et al. (2013) Design and synthesis of mimics of the T7-loop of FtsZ. Org Lett 15:2700-3
Brockway, Anthony J; Gonzalez-Lopez, Marcos; Fettinger, James C et al. (2011) Direct displacement of alkoxy groups of vinylogous esters by Grignard reagents. J Org Chem 76:3515-8
Park, Young Sam; Grove, Charles I; Gonzalez-Lopez, Marcos et al. (2011) Synthesis of (-)-viriditoxin: a 6,6'-binaphthopyran-2-one that targets the bacterial cell division protein FtsZ. Angew Chem Int Ed Engl 50:3730-3